The Boy Bosses of Silicon Valley Are on Their Way Out
The New York Times
They rode their unicorns to fame and fortune. In a rocky market, it got a little less fun.
More Related News
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.